A new dawn for managing dyslipidemias: The era of rna-based therapies
Year: 2019
Type: review
Source: Pharmacological Research
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: RNA therapeutics, dyslipidemia, atherosclerotic cardiovascular disease, PCSK9 inhibition, inclisiran, mipomersen, apolipoprotein B, lipoprotein(a), antisense oligonucleotides, volanesorsen, apolipoprotein C-III, ANGPTL3, triglyceride-rich lipoproteins, LDL cholesterol lowering, residual cardiovascular risk, lipid metabolism
Open Access status: bronze
OpenAlex ID: W2969846379
